Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The Topoisomerase II–DNA cleavage complex (TOP2cc) is a transient, covalent intermediate formed during the catalytic cycle of type II topoisomerases, which are essential enzymes that manage DNA topology by resolving knots and tangles [1, 6]. During its function, the enzyme creates a double-stranded break in a "gate" DNA segment, covalently binds to the 5' ends, and passes another DNA duplex through the gap before religating the break [3, 5, 7]. This complex is the specific target of "topoisomerase II poisons," such as etoposide and anthracyclines, which stabilize the intermediate and prevent the religation of the DNA strands [4, 8, 13]. By trapping the enzyme in this state, these drugs convert an essential cellular machine into a potent toxin that generates persistent double-strand breaks, ultimately triggering apoptosis in rapidly proliferating cancer cells [1, 10, 15]. However, the persistence of TOP2cc can also lead to deleterious genomic rearrangements, such as MLL gene translocations, which are associated with the development of secondary leukemias [3, 9, 14]. Furthermore, the interaction of drugs with the TOP2B isoform in non-proliferating cells like cardiomyocytes is a primary driver of treatment-related cardiotoxicity [8, 13].
Stabilization of the topoisomerase II-DNA cleavage complex and inhibition of DNA religation, leading to permanent double-strand breaks and apoptosis.
7 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on DNA topoisomerase 2-DNA cleavage complex (TOP2cc) (TOP2cc).